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AbstrACt
Objective Continuity of care is a long-standing feature of 
healthcare, especially of general practice. It is associated 
with increased patient satisfaction, increased take-up of 
health promotion, greater adherence to medical advice 
and decreased use of hospital services. This review aims 
to examine whether there is a relationship between the 
receipt of continuity of doctor care and mortality.
Design Systematic review without meta-analysis.
Data sources MEDLINE, Embase and the Web of Science, 
from 1996 to 2017.
Eligibility criteria for selecting studies Peer-reviewed 
primary research articles, published in English which 
reported measured continuity of care received by patients 
from any kind of doctor, in any setting, in any country, 
related to measured mortality of those patients.
results Of the 726 articles identified in searches, 22 
fulfilled the eligibility criteria. The studies were all cohort 
or cross-sectional and most adjusted for multiple potential 
confounding factors. These studies came from nine 
countries with very different cultures and health systems. 
We found such heterogeneity of continuity and mortality 
measurement methods and time frames that it was not 
possible to combine the results of studies. However, 
18 (81.8%) high-quality studies reported statistically 
significant reductions in mortality, with increased continuity 
of care. 16 of these were with all-cause mortality. Three 
others showed no association and one demonstrated mixed 
results. These significant protective effects occurred with 
both generalist and specialist doctors.
Conclusions This first systematic review reveals that 
increased continuity of care by doctors is associated 
with lower mortality rates. Although all the evidence is 
observational, patients across cultural boundaries appear 
to benefit from continuity of care with both generalist 
and specialist doctors. Many of these articles called 
for continuity to be given a higher priority in healthcare 
planning. Despite substantial, successive, technical 
advances in medicine, interpersonal factors remain 
important.
PrOsPErO registration number CRD42016042091.
IntrODuCtIOn
Medical science has advanced rapidly since 
the early 19th century. Major advances 
from the germ theory to the sequencing of 
the human genome have together gener-
ated much deeper understanding of the 
pathophysiology of disease with improved 
prevention and treatment. However, all 
these advances are mostly related to phys-
ical factors. Research on human aspects of 
medical care has lagged.
Internationally, there has been a decrease 
in the perceived value of personal contact 
between patients and doctors. An editorial in 
the New England Journal of Medicine1 suggested 
that non-personal care should become the 
‘default option’ in medicine.
One way to study interpersonal care is by 
measuring continuity of care. The definition 
of continuity of care that we have used previ-
ously2 is repeated contact between an indi-
vidual patient and a doctor. Such repeated 
contact gives patients and doctors the oppor-
tunity for improved understanding of each 
other’s views and priorities. Continuity of care 
can be considered to be a proxy measure for 
the strength of patient–doctor relationships.3
There have been a variety of approaches 
to measure continuity and so far only three 
randomised controlled trials have been 
completed.4–6 These all showed continuity to 
be beneficial for patients over relatively short 
strengths and limitations of this study
 ► The first systematic review of continuity of care and 
mortality.
 ► We included studies working with patients with all 
conditions, of all ages and of all stages of conditions.
 ► We included articles investigating continuity with all 
kinds of doctors in any health system.
 ► We included articles using any clearly defined mea-
sure of continuity of care.
 ► A meta-analysis was not possible due to heteroge-
neity of continuity and mortality measures.
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periods. However, RCTs are problematic with pre-ex-
isting long-term human relationships, like marriage and 
parent–child relationships, as prospective randomisation 
is almost impossible. Some doctor–patient relationships 
last for decades and become highly personal, and there-
fore RCTs are unethical or impractical. Observational 
studies have inherent limitations, and investigating conti-
nuity of care has certain problems, in particular that of 
reverse causality; poor health or death early in the study 
leading to a low measured level of continuity.7 However, 
study teams are increasingly aware of this and use study 
designs and analytical methods to reduce and account for 
it.
There is a clear rationale for the effectiveness of conti-
nuity of care as doctors collect ‘accumulated knowledge’8 
about an individual patient which they then use in subse-
quent consultations to tailor advice.
Continuity of care in general practice is associated with 
greater patient satisfaction,9 improved health promo-
tion,10 increased adherence to medication11 and reduced 
hospital use.12 Given all these separate benefits, the ques-
tion arises whether these extend to mortality rates. Death 
is clearly the most important and serious of all outcomes.
Since 2010, individual studies have emerged inves-
tigating whether continuity of care is associated with 
reduced mortality, including some with specialists.13–35 
These reports represent a new development, underlining 
the interpersonal component of medical care.
research question
Are higher levels of continuity of doctor care, in any 
setting, with any patient group, associated with changed 
mortality?
MEthODs
search strategy and selection criteria
For inclusion in this systematic review (without meta-anal-
ysis), articles must have been published in the peer-re-
viewed literature, in the last 21 years, in English. We 
searched the databases of MEDLINE, Embase and the 
Web of Science from 1996 to 2017 by searching for ‘conti-
nuity’ OR ‘continuity of care’ together with terms for a 
medical doctor/physician and terms indicating death or 
mortality in the title or abstract (see online supplemen-
tary information—example search strategy). In addition, 
references of articles selected were hand-searched for 
additional relevant citations.
Experimental and observational study designs were 
considered including controlled trials, cohort studies 
(prospective and retrospective) and case–control studies. 
Systematic reviews and meta-analyses were excluded. 
Study participants could include any patient group, 
including entire populations or groups of patients with a 
specific disease or other feature.
Articles must have compared measured degrees of 
continuity of care with doctors (of any kind) to mortality 
rates. Any valid measure of continuity was considered, 
including continuity being lost or absent and articles 
where the continuity measure was a single appointment 
or visit by a general practitioner/family physician during 
a hospital stay. Articles about organisational continuity 
and general staffing numbers were excluded.
As an outcome measure, any measure of mortality was 
accepted, that is, all-cause, time/age-limited or cause-spe-
cific. When complications or hospital admissions were 
combined with death rates, we sought a separate measure 
of mortality alone. If this was not available, studies were 
excluded.
Two pairs of reviewers checked the search results and 
decided independently whether papers met the eligibility 
criteria. Initially, the title and abstract of each citation 
was screened. The full texts of selected articles were then 
examined. Disagreements were resolved by discussion, 
and PHE independently had the deciding vote.
Data items
The variables and outcomes extracted included basic 
information: authors, date and country. We also extracted 
study design, study population (any particular condition, 
setting, age group, any other inclusion or exclusion 
criteria and selection method), numbers of patients, 
measure of continuity, length of continuity measure-
ment and doctor type (generalist doctor including 
general practitioner, family physician and primary care 
physician or specialist). We extracted the period of time 
for the mortality measurement, and any overlap with 
or interval between mortality and continuity measure-
ment periods. We also extracted whether mortality was 
all-cause or a disease-specific cause or limited to a partic-
ular group, how mortality was assessed and confounding 
factors tested or accounted for. We also extracted an esti-
mation of any association found, with risk ratio or OR 
where possible and whether higher continuity was linked 
to an increased or decreased mortality risk. Data were 
extracted independently by two reviewers (of DJPG, EW, 
AT and KSL), using the data-extraction table designed 
for this review. Disagreements were resolved as described 
previously.
risk of bias
The quality and risk of bias were assessed independently 
for individual studies by two reviewers using the Newcas-
tle-Ottawa Scale.36 We also assessed relevant areas of bias 
in terms of the timing of continuity and mortality measure-
ment and confounding factors considered. For continuity 
of care and mortality, there is a particular potential for 
bias in that the worsening of health status before death 
may cause either decreased or increased continuity of 
care (reverse causality),7 so we noted whether this had 
been considered and adjusted for in study design. In 
terms of bias across studies, we considered publication 
bias and reporting bias in terms of whether mortality was 
the primary outcome.
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Data analysis
Studies were analysed for a relationship between conti-
nuity of care and mortality rates, and whether this rela-
tionship was an inverse one (ie, greater continuity of care 
led to lower mortality rates) or not. For each study, we 
sought a risk metric (ie, relative risk ratio, HR or OR) 
from an adjusted model of data analysis in order to mini-
mise the risk of selection bias and confounding. Where 
these statistical metrics were not reported, we provided 
any other available comparison measure.
Patient involvement statement
DJPG is a member of the St Leonard’s Practice Patient 
Participation Group as well as the Patron of the National 
Association for Patient Participation. As such, he is a 
patient representative as well as an author. The research 
question and outcomes were therefore conceived by 
a patient from the practice based on the priorities, 
experience and preferences stated by patients at succes-
sive national patient conferences.
rEsults
study selection
After removal of duplicate results, 726 peer-reviewed 
publications were identified. No previous systematic 
reviews or trials on this subject were found. Of the 
726 papers identified, 43 papers were selected for full-
text review (figure 1). Articles were then excluded if 
continuity was not clearly measured or was the depen-
dent variable,37–42 if the continuity of care measure was 
not clearly with a doctor or doctors only35 43–49 and if 
mortality was not analysed or not analysed separately at 
any point50–52 (eg, if it was expressed only as a composite 
outcome with hospitalisation). This left 22 studies for 
inclusion.
Figure 1 Study selection flow diagram.
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study characteristics
As shown in table 1, the majority of included reports (15, 
68.2%) were of retrospective cohort studies, often using 
insurance data. There were four prospective cohort and 
three cross-sectional studies. No randomised controlled 
trials were found. A number of cohort studies included 
large numbers of patients (median 16 855). All of the 
reports were published since 2010. The studies were 
carried out in nine different countries; the majority were 
from North America (Canada 6, USA 5). Seven were from 
Europe (England 3, France 2, Croatia 1 and the Nether-
lands 1). There were two from Taiwan and one each from 
Israel and South Korea.
Nine (40.9%) of the studies investigated continuity 
with a general practitioner/family physician/primary 
care physician, 3 were with specialists only17 19 20 and 
10 included continuity with doctors of any kind. Eight 
studies (34.8%) selected patients during or following an 
index hospitalisation.15–18 20 25 26 29. Five studies studied 
patients with diabetes22 23 27 30 31 and three studies focused 
on older patients.13 24 31
The continuity measures used are reported in table 1. 
The most common measure used was the Usual Provider 
of Care (UPC) index which was used in 10 studies 
(45.5%).13 16 17 21 23 25 26 29–31 Six studies used more than 
one measure, some only for sensitivity analysis.13 21 25 26 28 29 
One study13 was designed to compare the association of 
different continuity measures with outcomes, including 
mortality. One article18 used the occurrence of a supportive 
visit by a family physician to a patient in hospital and 
another14 simply took loss of contact as meaning loss of 
continuity. Three studies32–34 used the results of a ques-
tion or questions from the annual UK national General 
Practice Patient Survey.
The length of time over which continuity was measured 
(when not a survey response or hospital visit indicating a 
relationship) varied greatly between studies, from a single 
weekend in hospital17 up to 17 years.24 The median length 
of continuity measurement was 2 years (IQR 3.75).
Most studies (20, 90.9%) reported all-cause mortality. 
One study32 investigated premature mortality; under 
the age of 75. Another33 used premature coronary heart 
disease mortality as the primary outcome. The length 
of time for recording deaths also showed a large varia-
tion between studies, from 30 days to up to 21 years. The 
median follow-up time was 2.5 years (IQR 4.4).
Most of the studies investigated a large number of 
potential confounding factors (table 1). All studies 
working at the level of individual patients included some 
measure of health status including LACE index, comor-
bidities, previous healthcare usage and other measures. 
Most studies looked at age and sex and 14 (63.6%) used a 
measure of deprivation, social status or income.
results of individual studies
Of the 22 studies, 18 (81.8%) showed that greater conti-
nuity of care was significantly associated with lower 
mortality. Of these, 16 (72.7% of the 22) were with lower 
all-cause mortality (table 2). Two studies found no asso-
ciation of greater continuity of care with subsequent 
mortality during17 or following16 a hospital stay. One study 
found that continuity was not significantly associated with 
mortality except in general practices in the least deprived 
areas.32 One study13 investigated a range of continuity 
measures. They found that all insurance claims-based 
measures showed that higher levels of continuity were 
associated with higher mortality rates but greater conti-
nuity as reported by patients was associated with reduced 
mortality. This is the only study showing any association of 
increased continuity with increased mortality.
Due to the heterogeneity of study continuity and 
mortality measurements, it was not possible to combine 
them to produce an estimate of effect size; however, 
table 2 shows the risk ratio, OR or HR from individual 
studies where available.
risk of bias within studies
Using the Newcastle-Ottawa Scale,36 all 22 studies were 
rated as high quality, with nine 10 studies (40.9%) gaining 
maximum scores from both reviewers independently 
(table 1, supplementary table). No study was scored less 
than 7 out of 9 by any reviewer. As all these studies were 
cohort or cross-sectional studies, they tested for associa-
tions only. However, most involved statistical analyses for 
a wide range of potential confounding factors (table 1).
The specific bias of reverse causality between the 
healthcare-related events that might occur before death 
was discussed in 14 (63.6%) of the studies. Four cohort 
studies did not discuss reverse causality.14 24 27 31 However, 
all of the studies included some measure of health/
disease status as a potential confounding factor and 
some included several detailed measures of these in their 
models.
Five of the studies had a design which meant there was no 
overlap between the time for continuity measurement and 
the period during which deaths were counted.13 20 22 28 30 
Seven studies have complete14 16 21 23 28 29 31 and four partial 
overlap of these periods.17 19 24 25 Five studies included 
additional analyses which either eliminated the overlap23 
or introduced a lag time19 21 26 28 between continuity and 
mortality measurement periods. In each of these addi-
tional analyses, continuity was still found to be signifi-
cantly associated with mortality. One long-term study24 
calculated survival from the date of the last continuity 
measurement and stratified by the length of time in the 
study. Five studies19 21 25 28 29 used their continuity score as 
a time-dependent variable in the model.
risk of bias across studies
There is a risk of publication bias. It may be that 
reports showing no effect are less likely to be published. 
However, two showed no association. In two, mortality 
was not the primary outcome and in six, it was part of 
a composite outcome. For 13 studies, mortality was not 
the only outcome. In 10 studies, the association of two 
or more factors, including doctor continuity of care, with 
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outcomes was tested. Continuity and mortality as expo-
sure and outcome, respectively, are reported in a range of 
studies, including where testing this association was not 
the primary aim.
DIsCussIOn
Principal findings
In a substantial majority of studies (18, 81.8%) meeting 
the selection criteria, higher levels of continuity of care 
with doctors were associated with lower mortality rates. 
Two others, finding no significant association, had very 
short timescales for measurement of continuity, to the 
extent that the strength of any patient–doctor relation-
ship was potentially questionable. Another study showing 
no significant association with all-cause mortality was 
cross-sectional, and the measurement methods related to 
questions on a national survey about seeing a particular 
general practitioner, again not necessarily indicative of a 
strong patient–doctor relationship.
One study8 found that for claims-based measures of 
continuity, increased mortality was associated with higher 
levels of continuity of care. However in the same study, 
higher levels of patient-reported continuity were asso-
ciated with lower mortality rates. This emphasises the 
interpersonal relationship between patient and doctor as 
claims-based measures only give numbers of contacts and 
do not directly measure the quality of the relationship.
The effect sizes were generally small (table 2) but these 
were in the same range as some treatment effects, as very 
large, repeatable effects on mortality are rare.53 In addi-
tion, for some studies included in this review, effect sizes 
were calculated using very small increments in the conti-
nuity measure.
strengths and weaknesses of the evidence
All the studies found investigating the association of conti-
nuity of care with mortality were observational in nature, 
although the majority were high-quality cohort studies 
including three prospective cohort studies. The issue of 
reverse causality applies to all the evidence presented 
here. This could bias an association between continuity 
of care and mortality in either direction. As patient health 
worsens when approaching death, continuity of care 
may deteriorate for many reasons, for example, patients 
moving areas to accommodate increased health needs, 
the need to see more specialists or a loss of ability to 
obtain and attend appointments. Alternatively, deteriora-
tion of health could lead to a concerned doctor ensuring 
that the patient receives more continuity of care. For 
the cross-sectional studies, there is also a potential for 
confounding due to practice-level factors.
There have been randomised controlled trials into 
continuity of care but none on existing relationships or 
lasting longer than a year and none with mortality as an 
outcome.4–6 Observational studies which control rigor-
ously for confounding factors and have a design aimed 
at limiting the impact of reverse causality are the best 
evidence available.
Of the 16 cohort studies finding an association of 
higher continuity with lower mortality, most studies 
attempt to at least partially account or control for reverse 
causality in their study design or analysis. Most controlled 
for differences in health status and risk factors. Some 
carried out analyses measuring continuity and mortality 
in separate years, or with a lag. This method, particularly 
the lag between measurements, should help to minimise 
bias caused by rapid worsening prior to death. However, 
four cohort studies showing this association14 24 27 31 did 
not discuss this kind of reverse causality although one24 
nevertheless made several adjustments for health status 
and calculated survival from the date of the last conti-
nuity measurement. Measuring continuity and mortality 
over separate time periods is also one way of eliminating 
the potential bias caused by those who survived longer 
having more time to accrue continuity (time-dependent 
bias). Another way of reducing this is to model continuity 
as a time-dependent variable which was the case in five 
studies.19 21 25 28 29
All studies included were rated as high quality, using 
the Newcastle-Ottawa Scale.
Several of the articles reported on studies using very 
large cohorts. The studies came from a number of 
different countries with different healthcare systems 
and cultures. Continuity of care in the studies included 
that received from specialist as well as generalist doctors, 
showing that the effect is not limited to one branch of 
medicine or health system.
As continuity research is an emerging field, no 
consensus on the best way to measure it has been reached. 
The measure used most was the UPC Index which does 
not take into account the total number, frequency or 
sequence of visits.54
Doctors have been studied as a discrete category in 
numerous studies, and data systems usually allow them to 
be separately studied. The group studied included family 
doctors/general practitioners, physicians and psychia-
trists so was already heterogeneous so expanding this to 
other professional groups would have complicated inter-
pretation. As doctors are the most highly trained health 
professionals with the most influence over decisions, 
it is reasonable to assume that if interpersonal contact 
affects mortality, it is most likely to occur with doctors. 
Therefore, we eliminated articles, some with significant 
reductions in mortality, that measured continuity in 
relation to mixed profession teams or to other health 
professionals.35 43–49 This is the first systematic review 
investigating whether continuity of doctor care is associ-
ated with reduced mortality. We expect this to encourage 
studies with different selection criteria; for example, for 
continuity with other healthcare professionals.
Possible mechanisms and implications
This review, finding that increased receipt of continuity 
of care is associated with reduced mortality, comes after it 
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has been shown that continuity of care is associated with 
multiple benefits for patients.9–12 It therefore fits well with 
such earlier work. It is only recently that large databases 
and long-term cohort studies have made effective inves-
tigation into the links between continuity and mortality 
possible.
These known associations suggest possible mechanisms 
in that greater uptake of evidence-based preventative 
medicine such as immunisations as well as better concor-
dance with treatments is likely to reduce mortality. Conti-
nuity of care is associated with patients perceiving that 
the doctor has become more responsive.55Patients then 
disclose more and medical management is more likely 
to be tailored to the needs of the patient as a person. 
The increased patient satisfaction may also be associated 
with an ‘optimism’ boost to health.56 We have previously 
suggested that ‘doctors tend to overestimate their effec-
tiveness when consulting with patients they do not know, 
and underestimate their effectiveness when consulting 
with patients they know’.57
The cumulative impact of these multiple gains may 
then be reflected in reduced mortality.
Historically, continuity of care has been considered a 
feature of the practice of medical generalists and featured 
in the job descriptions of the general practitioner.58 59 
Recent studies included in this review found that conti-
nuity was associated with reduced mortality with specialist 
physicians,22 28 psychiatrists19 and surgeons20 too.
Although this evidence is observational, with 18 of the 
22 studies showing significant reductions in mortality 
with continuity of doctor care, the clear preponderance 
of evidence is in favour of the association. Three studies 
showed no significant association and one13 had mixed 
results but no study exclusively showed an association 
of higher continuity of care with higher mortality rates. 
Although there are difficulties in carrying out controlled 
trials on this subject, a few, with interventions to increase 
continuity of care, have been successful,4–6 and this could 
be attempted more widely. The presence of this associ-
ation in nine countries, across three continents, and in 
very different populations and healthcare systems implies 
a basic human effect.60 The policy implication as many 
studies noted is prioritising continuity of care.
For 200 years, medical advances have been mainly tech-
nical and impersonal which has reduced attention to the 
human side of medicine. This systematic review reveals 
that despite numerous technical advances, continuity 
of care is an important feature of medical practice, and 
potentially a matter of life and death.
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